Article Details
Retrieved on: 2023-11-09 20:37:40
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Aspira Women's Health Inc. The proposed rule would allow for OvaWatchSM to be reimbursed at the same rate as Ova1® at $897 per test ...
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here